Trial intelligence / Profile preview

HSK21542 Injection for Postoperative Analgesia after Elective Laparoscopic Abdominal Surgery (Phase III)

CTR20210256Phase 3Completed

Sponsor
Haisco Pharmaceutical Group Co., Ltd.
Start
Mar 2021
Modality
Small Molecules, Peptides
Countries
1
01

Overview

A Phase 3 trial of hsk21542 in postoperative pain, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Mar 2021; status: completed.

02

Drugs

hsk21542
03

Conditions

postoperative pain

Beyond the preview

Go deeper on CTR20210256.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20210256.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call